List of Tables
Table 1. Global Leishmaniasis Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Meglumine Antimoniate
Table 3. Key Players of Pentamidine
Table 4. Key Players of Hydroxyl Amidine Stilbene
Table 5. Key Players of Amphotericin B
Table 6. Global Leishmaniasis Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Leishmaniasis Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Leishmaniasis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Leishmaniasis Treatment Market Share by Region (2019-2024)
Table 10. Global Leishmaniasis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Leishmaniasis Treatment Market Share by Region (2025-2030)
Table 12. Leishmaniasis Treatment Market Trends
Table 13. Leishmaniasis Treatment Market Drivers
Table 14. Leishmaniasis Treatment Market Challenges
Table 15. Leishmaniasis Treatment Market Restraints
Table 16. Global Leishmaniasis Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Leishmaniasis Treatment Market Share by Players (2019-2024)
Table 18. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leishmaniasis Treatment as of 2023)
Table 19. Ranking of Global Top Leishmaniasis Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Leishmaniasis Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Leishmaniasis Treatment Product Solution and Service
Table 23. Date of Enter into Leishmaniasis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Leishmaniasis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Leishmaniasis Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Leishmaniasis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Leishmaniasis Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Leishmaniasis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Leishmaniasis Treatment Revenue Market Share by Application (2019-2024)
Table 31. Global Leishmaniasis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Leishmaniasis Treatment Revenue Market Share by Application (2025-2030)
Table 33. North America Leishmaniasis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Leishmaniasis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Leishmaniasis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Leishmaniasis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Leishmaniasis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Leishmaniasis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Leishmaniasis Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Leishmaniasis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Leishmaniasis Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Leishmaniasis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Leishmaniasis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Leishmaniasis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Leishmaniasis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Leishmaniasis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Leishmaniasis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. Merck Company Detail
Table 49. Merck Business Overview
Table 50. Merck Leishmaniasis Treatment Product
Table 51. Merck Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)
Table 52. Merck Recent Development
Table 53. iCo Therapeutics Company Detail
Table 54. iCo Therapeutics Business Overview
Table 55. iCo Therapeutics Leishmaniasis Treatment Product
Table 56. iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)
Table 57. iCo Therapeutics Recent Development
Table 58. AEterna Zentaris Company Detail
Table 59. AEterna Zentaris Business Overview
Table 60. AEterna Zentaris Leishmaniasis Treatment Product
Table 61. AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)
Table 62. AEterna Zentaris Recent Development
Table 63. AEterna Zentaris AG Company Detail
Table 64. AEterna Zentaris AG Business Overview
Table 65. AEterna Zentaris AG Leishmaniasis Treatment Product
Table 66. AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)
Table 67. AEterna Zentaris AG Recent Development
Table 68. Eurofins Advinus Company Detail
Table 69. Eurofins Advinus Business Overview
Table 70. Eurofins Advinus Leishmaniasis Treatment Product
Table 71. Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)
Table 72. Eurofins Advinus Recent Development
Table 73. Pieris Pharmaceuticals Company Detail
Table 74. Pieris Pharmaceuticals Business Overview
Table 75. Pieris Pharmaceuticals Leishmaniasis Treatment Product
Table 76. Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)
Table 77. Pieris Pharmaceuticals Recent Development
Table 78. Dafra Pharma Company Detail
Table 79. Dafra Pharma Business Overview
Table 80. Dafra Pharma Leishmaniasis Treatment Product
Table 81. Dafra Pharma Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)
Table 82. Dafra Pharma Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leishmaniasis Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Leishmaniasis Treatment Market Share by Type: 2023 VS 2030
Figure 3. Meglumine Antimoniate Features
Figure 4. Pentamidine Features
Figure 5. Hydroxyl Amidine Stilbene Features
Figure 6. Amphotericin B Features
Figure 7. Global Leishmaniasis Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Leishmaniasis Treatment Market Share by Application: 2023 VS 2030
Figure 9. Visceral Leishmaniasis Case Studies
Figure 10. Cutaneous Leishmaniasis Case Studies
Figure 11. Leishmaniasis Treatment Report Years Considered
Figure 12. Global Leishmaniasis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Leishmaniasis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Leishmaniasis Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Leishmaniasis Treatment Market Share by Players in 2023
Figure 16. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leishmaniasis Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Leishmaniasis Treatment Revenue in 2023
Figure 18. North America Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Leishmaniasis Treatment Market Share by Country (2019-2030)
Figure 20. United States Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Leishmaniasis Treatment Market Share by Country (2019-2030)
Figure 24. Germany Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Leishmaniasis Treatment Market Share by Region (2019-2030)
Figure 32. China Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Leishmaniasis Treatment Market Share by Country (2019-2030)
Figure 40. Mexico Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Leishmaniasis Treatment Market Share by Country (2019-2030)
Figure 44. Turkey Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Merck Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)
Figure 47. iCo Therapeutics Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)
Figure 48. AEterna Zentaris Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)
Figure 49. AEterna Zentaris AG Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)
Figure 50. Eurofins Advinus Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)
Figure 51. Pieris Pharmaceuticals Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)
Figure 52. Dafra Pharma Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed